Strategy for development of generic drug superstars in China

Wei Ping Su, Rui Lin Song, Yi Tao Wang, Lu Wen Shi

Research output: Contribution to journalArticle

Abstract

Developing our own generic drug superstars is one of the ways to vitalize our national pharmaceutical industry. After a systematic analysis of the success of Indian and American generic drug industries, we concluded a development model of generic drug superstars. Besides, we brought up several major policies for the development of our own generic drug superstars, including the supervision policy on drug quality and drug clinical outcomes, and the encouragement policy on drug supply and sales.

Original languageEnglish (US)
Pages (from-to)200-203
Number of pages4
JournalChinese Journal of New Drugs
Volume20
Issue number3
StatePublished - Mar 31 2011

Keywords

  • Generic drug superstars
  • Quality control
  • Supply and sales regulation

Fingerprint Dive into the research topics of 'Strategy for development of generic drug superstars in China'. Together they form a unique fingerprint.

  • Cite this

    Su, W. P., Song, R. L., Wang, Y. T., & Shi, L. W. (2011). Strategy for development of generic drug superstars in China. Chinese Journal of New Drugs, 20(3), 200-203.